The Skindex instruments to measure the effects of skin disease on quality of life
- PMID: 22284137
- PMCID: PMC3269028
- DOI: 10.1016/j.det.2011.11.003
The Skindex instruments to measure the effects of skin disease on quality of life
Abstract
Skindex-29 and Skindex-16 are validated measures of the effects of skin diseases on patients' quality of life. This article reviews the development of both versions of Skindex, discusses their measurement properties and interpretability, and gives examples of how they have been used and adapted for dermatologic research internationally. Studies of quality of life in patients with nonmelanoma skin cancer are described to illustrate the use of Skindex to understand quality of life and to compare effectiveness of different treatments for this highly prevalent condition.
Published by Elsevier Inc.
Figures
References
-
- Finlay AY, Kelly SE. Psoriasis--an index of disability. Clin Exper Dermatol. 1987;12:8–11. - PubMed
-
- Finlay AY, Khan GK. Dermatology life quality index (DLQI)--a simple practical measure for routine clinical use. Clin Exper Dermatol. 1994;19:210–216. - PubMed
-
- Kirshner B, Guyatt G. A methodological framework for assessing health indices. J Chron Dis. 1985;38(1):27–36. - PubMed
-
- Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol. 1996;107:707–713. - PubMed
-
- Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol. 1997;133(11):1433–1440. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
